Cointime

Singlera Genomics

company

About

Singlera Genomics is a fast growing company focusing on non-invasive genetic testing.

  • 51 - 100

Highlights

Total Funding Amount
$230M
Funding Rounds
3
Investors
4

Details

Last Funding Type
Series B
Last Funding Money Raised
$150M
Industries
Biotechnology,Genetics,Health Care,Health Diagnostics,Medical
Founded date
Jul 1, 2014
Number Of Employee
51 - 100
Operating Status
Active

Singlera Genomics is a fast growing company focusing on non-invasive genetic testing. Singlera’s main products and services include tumor diagnosis and personalized treatment, non-invasive prenatal diagnosis, pre-implantation genetic screening, and customized scientific research services. Singlera is dedicated to the development of precision medicine, striving to help the patients through early, accurate and informative diagnoses.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$230M
Singlera Genomics has raised a total of $230M in funding over 2 rounds. Their latest funding was raised on Dec 15, 2020 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 15, 2020 Series B $150M 2 — — Detail
Mar 27, 2018 Series A $60M 3 Prosperico Ventures — Detail
Aug 22, 2016 Series A $20M 1 Lilly Asia Ventures — Detail

Investors

Number of Lead Investors
Number of Investors
2
4
Singlera Genomics is funded by 4 investors. FutureX Skyline Capital and Prosperico Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
FutureX Skyline Capital — Series B
Prosperico Ventures — Series B
UCF Medical Investment — Series A
Lilly Asia Ventures — Series A
Cointime
เนื้อหา
บริษัท